Related Experiment Video
Updated: May 18, 2026
Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Cell-based strategies to reconstitute lung function in infants with severe bronchopulmonary dysplasia
Megan O'Reilly1, Bernard Thébaud
1Department of Pediatrics, Women and Children Health Research Institute, University of Alberta, 87 Avenue, T6G 1C9, Edmonton, Alberta, Canada.
Insights
Stem/progenitor cells show promise for treating neonatal lung injury, particularly bronchopulmonary dysplasia. Research is advancing cell-based therapies for this common prematurity complication, though challenges remain.
Area of Science:
- Regenerative Medicine
- Neonatal Physiology
- Pulmonology
Background:
- Neonatal lung injury, especially bronchopulmonary dysplasia (BPD), is a significant complication in extremely preterm infants.
- Current treatments for BPD are limited, highlighting the need for novel therapeutic approaches.
- Advances in stem/progenitor cell biology offer potential for organ repair.
Purpose of the Study:
- To review the fundamental concepts of stem/progenitor cell biology.
- To discuss the current state of cell-based therapies for lung diseases.
- To focus on the application of these therapies for neonatal lung injury and BPD.
Main Methods:
- Literature review of recent advances in stem/progenitor cell research.
- Analysis of studies on cell-based treatments for lung diseases.
- Focus on preclinical and clinical data relevant to BPD.
Main Results:
- Stem/progenitor cells possess regenerative potential for damaged lung tissue.
- Cell-based therapies are emerging as a promising strategy for neonatal lung injury.
- Significant challenges persist in translating these therapies into effective BPD treatments.
Conclusions:
- Stem/progenitor cell therapy represents a potential breakthrough for treating BPD.
- Further research is crucial to overcome hurdles in efficacy and delivery for clinical application.
- Cell-based approaches offer hope for improving outcomes in extremely preterm infants with lung disease.
Abstract:
Recent advances in our understanding of stem/progenitor cells and their potential to repair damaged organs offer the possibility of cell-based treatments for neonatal lung injury. This review summarizes basic concepts of stem/progenitor cell biology and discusses the recent advances and challenges of cell-based therapies for lung diseases, with a particular focus on bronchopulmonary dysplasia (BPD), a form of chronic lung disease that primarily affects very preterm infants. Despite advances in perinatal care, BPD still remains the most common complication of extreme prematurity, and there is no specific treatment.
